mRNA analysis

mRNA analysis

featured image of Revolutionizing CAR T: Cut Costs and Boost Access!

Revolutionizing CAR T: Cut Costs and Boost Access!

BIOT

Unlocking CAR T therapies for all! 🌎💡 Decentralization, AI, and innovative alternatives are key to reducing costs and enhancing access. 🏥🧬🤖🛠️

featured image of NIIMBL Grants Fuel Game-Changing Biotech Innovations!

NIIMBL Grants Fuel Game-Changing Biotech Innovations!

BIOT

🌟 NIIMBL grants boost biopharmaceutical innovation! 📊 Funding real-time analytics, mAb, and mRNA projects for efficient production. 🚀✨

featured image of Unlocking mRNA Success Through Strategic Partnerships

Unlocking mRNA Success Through Strategic Partnerships

BIOT

Unlock mRNA vaccine success! 🌟 Explore manufacturing challenges, quality analytics, and innovative partnerships with experienced CDMOs for optimal results. 🤝🔬📈

featured image of Revolutionary TFF Boosts mRNA Purity and Production!

Revolutionary TFF Boosts mRNA Purity and Production!

BIOT

Optimizing TFF enhances mRNA purification! 🚀 Minimized fouling achieves 3 loss, boosting cost-effective vaccine production. 💉🔬 mRNA Biotech

featured image of Revolutionary mRNA Factory Opens in Singapore!

Revolutionary mRNA Factory Opens in Singapore!

BIOT

🌟 Exciting news! A new mRNA BioFoundry in Singapore combines advanced tech and AI for enhanced nucleic acid therapeutics production! 🤖💡🌐

featured image of Revolutionary RNA Production Tech Promises Faster Therapies!

Revolutionary RNA Production Tech Promises Faster Therapies!

BIOT

🔬 Quotient Sciences installs a state-of-the-art GMP Biofoundry-in-a-Box for automated RNA production, revolutionizing therapy development! 🚀🌱💡📈

featured image of Revolutionizing mRNA Production: Key Innovations Ahead!

Revolutionizing mRNA Production: Key Innovations Ahead!

BIOT

🚀 Discover how innovations in mRNA manufacturing post-COVID-19 are transforming vaccine production with efficiency and reliability! 💉🔬 Biologics Innovation

featured image of Agilent's $925M Biovectra Buy: Boosting Growth!

Agilent’s $925M Biovectra Buy: Boosting Growth!

BIOT

Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦

featured image of Boost mRNA Manufacturing with Digital Optimization

Boost mRNA Manufacturing with Digital Optimization

BIOT

📰 Researchers in Germany developed a digital model to optimize mRNA manufacturing, resulting in increased production and reduced truncation. 💻💉

featured image of Revolutionizing Nucleic Acid Manufacturing with Digital Innovation

Revolutionizing Nucleic Acid Manufacturing with Digital Innovation

BIOT

📰 Scientists at Penn State highlight the need for digital innovation to enhance nucleic acid manufacturing efficiency. 💡💻🧬

12 Next